Subcutaneous injection scale: Psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medication

HIV Clinical Trials

Volumn 3, Issue 5, 2002, Pages 387-395

  Green, Jesse ^a   Kleinman, Leah ^a   Ciesla, Gabrielle ^a   Huang, Joanna ^a   Wintfield, Neil ^a   Revicki, Dennis ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

HIV; Self injection; Treatment satisfaction

Indexed keywords

ANTIMIGRAINE AGENT; ANTIRETROVIRUS AGENT; ENFUVIRTIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GLYCOPROTEIN GP 41; PEPTIDE FRAGMENT;

ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DATA ANALYSIS; EXPERIENCE; FACTORIAL ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF INJECTION; STATISTICAL ANALYSIS; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG SELF ADMINISTRATION; HEALTH SURVEY; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; ANTI-HIV AGENTS; FEMALE; HEALTH SURVEYS; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PEPTIDE FRAGMENTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 0036708580     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/tt4m-wkff-jtj7-vqu6     Document Type: Article

References (16)

1. Shikiar R, Rentz A. Satisfaction with Medication: An Overview of Conceptual, Methodological, and Regulatory Issues. Bethesda, MD: Center for Health Outcomes Research, MEDTAP International; May 2002.
2. Weaver M, Patrick DL, Markson LE, Martin D, Jhunnaya F, Berger M. Issues in the measurement of satisfaction with treatment. Am J Manag Care. 1997;3:579-594.
3. Mauskopf J, Lacey L, Kempel A, Simpson K. The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates. Am J Manag Care. 1998;4(7):1004-1012.
4. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the medical outcomes study. Med Care. 1991;29:786-798.
5. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481-493.
6. Cohen C, Revicki DA, Nabulsi A, et al. A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. AIDS. 1998;12:1495-1502.
7. Revicki DA, Moyle G, Stellbrink HJ, Barker C, for the PISCES (SV14604) Study Group. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 counts between 50 and 350 cubic millimeter. AIDS. 1999;13:851-858.
8. 3. Antiviral Ther. 1999;4:35-44.
9. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. 2nd ed. New York: Oxford University Press; 1995.
10. Nunally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
11. Kaplan PF, Austin DJ, Freund R. Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles. Am J Obstet Gynecol. 2000;182:1421-1426.
12. Gross MLP, Kay J, Turner AM, Jewsbury J, Cleal AL. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector. Headache. 1995;35:601-606.
13. Bouchard J, Cortelli P, Dahlof C, et al. A multinational investigation of the impact of subcutaneous sumatriptan IV: patient satisfaction. Pharmacoeconomics. 1997;11(suppl 1):43-50.
14. Cappelleri JC, Gerber RA, Kourides IA, Gelfand RA. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type I diabetes. Diabetes Care. 2000;23:1799-1803.
15. Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care. 1994;17:874-878.
16. Cohen CJ, Dusek A, Green J, Johns EL, Nelson E, Recny MA. Long-term treatment with subcutaneous T-20, a fusion inhibitor, in HIV-infected patients: patient satisfaction and impact on activities of daily living. AIDS Patient Care STDs. In press.